Epidemiology of febrile neutropenia in adult patients with acute leukemia and lymphoma. Cohort study of public and private hospital of Santiago, Chile

被引:12
作者
Rabagliati, Ricardo [1 ]
Bertin, Pablo [2 ]
Ceron, Ines [5 ]
Rojas, Hernan [6 ]
Dominguez, Isabel [5 ]
Vera, Alvaro [5 ]
Siri, Leonardo [1 ]
Flores, Jimena [1 ]
Fernandez, Paulina [6 ]
Perez, Marco [3 ]
De La Cruz, Rolando [4 ]
机构
[1] Pontificia Univ Catolica Chile, Fac Med, Dpto Enfermedades Infecciosas Adulto, Santiago, Chile
[2] Pontificia Univ Catolica Chile, Fac Med, Dpto Hematol & Oncol, Santiago, Chile
[3] Pontificia Univ Catolica Chile, Fac Med, Santiago, Chile
[4] Pontificia Univ Catolica Chile, Fac Med, Dept Salud Publ, Santiago, Chile
[5] Hosp Dr Sotero del Rio, Unidad Infectol, Santiago, Chile
[6] Hosp Dr Sotero del Rio, Unidad Hematol, Santiago, Chile
来源
REVISTA CHILENA DE INFECTOLOGIA | 2014年 / 31卷 / 06期
关键词
Febrile neutropenia; leukemia; lymphoma; invasive bacterial infections; invasive fungal disease; INVASIVE FUNGAL DISEASE; CANCER; RISK; CHEMOTHERAPY; INFECTION; FEVER; PROPHYLAXIS; PREDICTORS; EXPERIENCE; CHILDREN;
D O I
10.4067/S0716-10182014000600013
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: Febrile neutropenia (FN) is a common complication of patients undergoing chemotherapy (QMT). Clinical presentation is varied, from mild fever to severe sepsis with invasive bacterial infection (IBI) or invasive fungal infection (IFI), with great impact on prognosis and patient mortality. Patients and Methods: Prospective cohort study of FN episodes in adult patients with acute leukemia (AL) or lymphoma (L), diagnosed and treated at the Hospital Clinico Universidad Catolica and Hospital Dr. Sotero del Rio in Santiago from April 2010 to January 2012. Results: 130 patients were included with 105 episodes of NF, with an incidence of 0.65 per 100 days of observation, higher in AL than L (1.31 vs 0.25, p = 0.001). Etiology or clinical focus was documented in 67 (63.8%) episodes, with IBI in 33 (31.4%) and IFI in 21(20%) cases. Mortality related to infection occurred in 4 (6.2%) patients. Conclusions: This study reports that the FN incidence and frequency of IBI and IFI during episodes are higher in AL vs. L. It is necessary to evaluate the impact of interventions to reduce its incidence, including the benefit and risk of using antibacterial and antifungal prophylaxis in high-risk subgroups.
引用
收藏
页码:721 / 728
页数:8
相关论文
共 30 条
  • [1] Etiology of febrile neutropenia episodes among cancer patients from Hospital Clinico Universidad Catolica, Santiago-Chile
    Rabagliati B, Ricardo
    Fuentes L, Gino
    Orellana U, Eric
    Oporto C, Jorge
    Dominguez M, Isabel
    Benitez G, Rosana
    Aedo C, Igor
    Ramos G, German
    Garrido S, Marcelo
    Garcia C, Patricia
    REVISTA CHILENA DE INFECTOLOGIA, 2009, 26 (02): : 106 - 113
  • [2] Levofloxacin for febrile neutropenia prophylaxis in acute myeloid leukemia patients associated with reduction in hospital admissions
    Lee, Samantha S. F.
    Fulford, Adrienne E.
    Quinn, Maureen A.
    Seabrook, Jamie
    Rajakumar, Irina
    SUPPORTIVE CARE IN CANCER, 2018, 26 (05) : 1499 - 1504
  • [3] High risk febrile neutropenia in acute leukemia. The experience of a public hospital
    Puga, B
    Puga, I
    Cabrera, ME
    Undurraga, MS
    Guerra, C
    Urrejola, G
    Toro, P
    REVISTA MEDICA DE CHILE, 2003, 131 (09) : 1023 - 1030
  • [4] Levofloxacin for febrile neutropenia prophylaxis in acute myeloid leukemia patients associated with reduction in hospital admissions
    Samantha S. F. Lee
    Adrienne E. Fulford
    Maureen A. Quinn
    Jamie Seabrook
    Irina Rajakumar
    Supportive Care in Cancer, 2018, 26 : 1499 - 1504
  • [5] Clinical factors predictive of recurrent febrile neutropenia in adult patients with acute leukemia
    Wanitpongpun, Chinadol
    Teawtrakul, Nattiya
    Lanamtieng, Theerin
    Chansung, Kanchana
    Sirijeerachai, Chittima
    Amampai, Worakamol
    Sawanyawisuth, Kittisak
    LEUKEMIA RESEARCH REPORTS, 2022, 17
  • [6] An Emergent Change in Epidemiologic and Microbiological Characteristics of Bloodstream Infections in Adults With Febrile Neutropenia Resulting From Chemotherapy for Acute Leukemia and Lymphoma at Reference Centers in Chile, Ecuador, and Peru
    Rabagliati, Ricardo
    Salazar, Grace
    Perez-Lazo, Giancarlo
    Iturrieta, Maria Paz
    Portillo, Diana
    Soria-Segarra, Carmen
    Ojeda, Maria Jose
    Flores, Jimena
    Galarza, Margarita
    Sandoval-Ahumada, Roxana
    Cartes Aguilera, Pablo
    Dimitrakis, Lady
    Reinoso, Fabiola Avelga
    Garcia, Patricia
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (03):
  • [7] Doripenem versus meropenem as first-line empiric therapy of febrile neutropenia in patients with acute leukemia: a prospective, randomized study
    Oyake, Tatsuo
    Takemasa-Fujisawa, Yuka
    Sugawara, Norifumi
    Mine, Takahiro
    Tsukushi, Yasuhiko
    Hanamura, Ichiro
    Fujishima, Yukiteru
    Aoki, Yusei
    Kowata, Shugo
    Ito, Shigeki
    Ishida, Yoji
    ANNALS OF HEMATOLOGY, 2019, 98 (05) : 1209 - 1216
  • [8] Epidemiology of febrile neutropenia in adult patients with hematologic neoplasms in a period of 26 months in Hospital Pablo Tobon Uribe, Colombia
    Madrid, Camilo
    Diaz, Laura
    Combariza, Juan
    Galvez, Kenny
    Olaya, Viviana
    Ramirez, Isabel
    Donado, Jorge
    REVISTA CHILENA DE INFECTOLOGIA, 2013, 30 (02): : 195 - 201
  • [9] Human papillomavirus (HPV) genotypes in cervix uterine cancer patients in a public hospital and private clinic from Santiago, Chile
    Valdivia L, Isabel M.
    Aguayo G, Francisco
    Pruyas A, Martha
    Snijders, Peter J. F.
    Corvalan R, Alejandro
    Ferreccio R, Catterina
    REVISTA CHILENA DE INFECTOLOGIA, 2010, 27 (01): : 11 - 16
  • [10] Efficacy Profile of Daily Injection Filgrastim in Chemotherapy-Induced (CT) Febrile Neutropenia (FN) in Patients With Acute Leukemia (AL): Ukrainian Retrospective Study in a Real-Life Cohort
    Lymanets, Tetiana
    Skrypnyk, Igor
    Maslova, Anna
    Gusachenko, Iuliia
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S290 - S291